Good Results Stop Novartis’ Phase III Everolimus Trial
Oral mTOR inhibitor could beat Wyeth’s IV Torisel in kidney cancer, Novartis exec tells “The Pink Sheet” DAILY.
Oral mTOR inhibitor could beat Wyeth’s IV Torisel in kidney cancer, Novartis exec tells “The Pink Sheet” DAILY.